Free Shipping on orders over $250
Product Name
CJC-1295 With DAC
$125.00
A long-acting GHRH analog incorporating a Drug Affinity Complex, studied for prolonged GHRH-receptor signaling and peptide-albumin interactions.
Research Focus
GHRH Receptor Signaling • Growth Hormone Axis • Pituitary Biology • Peptide–Albumin Binding • Endocrine Signaling • Extended Peptide Stability
Research Disclaimer: Avante Peptides products are for laboratory and scientific research only and are not intended for human consumption, veterinary use, clinical application, or therapeutic treatment. All research must be conducted by qualified professionals in appropriate laboratory environments.
CJC-1295 with DAC is a synthetic 29-amino-acid growth hormone-releasing hormone (GHRH) analog developed for research involving prolonged GHRH-receptor signaling and endocrine pathway regulation.
The peptide incorporates a Drug Affinity Complex (DAC) that enables covalent binding to serum albumin, providing researchers with a model for investigating extended peptide stability and prolonged receptor activity.
Research involving CJC-1295 with DAC has examined GHRH receptor signaling, pituitary biology, growth-hormone-axis regulation, peptide–albumin interactions, endocrine signaling, and extended-duration peptide pharmacology.
| Attributes | Value |
|---|---|
| Dimensions | 0.66 × 0.66 × 1.5 in |
| Strength |
5mg |
| Research Focus |
GHRH Receptor Signaling • Growth Hormone Axis • Pituitary Biology • Peptide–Albumin Binding • Endocrine Signaling • Extended Peptide Stability |